Outside actors already moving: management's forward story is carried by at least two independent external parties whose
The model's full reasoning — Q1 2024 call → NOWe need answer YES/NO. Need analyze transcript. Need determine if management explains business about to be meaningfully larger carried primarily by already-taken actions of external parties, at least two separate external parties/groups, and reported numbers lag. Let's parse. Company AngioDynamics. Q1 FY2024. They discuss growth. Key areas: NanoKnife, Auryon, mechanical thrombectomy, Med Device. Need see forward story rests on outsiders already done? Management points to concrete actions by customers/partners? Let's examine. Jim: "NanoKnife business performed very well and grew approximately 36% during first quarter... NanoKnife growth was strong again internationally, as our international team continues to establish new relationships with partners who assist in supporting our procedures and our strong U.S. growth was driven by continuing interest in this technology as more physicians become aware of our direct and preserved trials." This is about growth already happening. But forward story? They mention PRESERVE study enrolled final patient, will submit FDA. That's company's clinical trial, not external party action? FDA approval future. International businesses grew 26% year-over-year with impressive growth from both Med Tech and Med Device. "Our team is strong and we will continue to grow in international markets through a strategy that employs key partners to support our products, continued exposure through our series of scientific symposiums, and further expansion of our Med Tech portfolio, as we gain important regulatory approvals around the globe." This is company's strategy, not external actions. Mechanical thrombectomy declined. AngioVac down but sequentially up. They received breakthrough designation, FDA conversations. APEX PE study 75% enrolled. This is company's clinical study, not external party action. Auryon grew 26%. "We continue to gain share because physicians are gaining confidence in our technology, while they are also getting exposure to data generated by their peers..." That's external adoption? But not specific. Med Device segment posted solid results, ports grew 22%. "illustrate strength and leadership of our vascular access product portfolio and our commercial team. This is a very competitive market and our team has continually shown the ability to win." That's company's own.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
MEC · Q3 2022 → YESThe question is about whether management explains why the company's business is about to be meaningfully larger based on already-taken actions of external parties, with at least two separate such part...YES The transcript shows management attributing meaningful future growth primarily to external customer actions already taken: specific awards and wins (e.g., large family of parts for electric side-by-side with full 2023 launch; high-value takeover project for ag customer; reshoring project closed for commercial vehicle customer starting early 2023; 2023 production ramp at Hazel Park facility; incremental business from light-duty truck platform). These are concrete, past-tense commitments from distinct customers (existing side-by-side customer, ag customer, commercial vehicle customer, light-duty truck engine manufacturer, new industrial infrastructure customer), with volumes and ramps explicitly described as beginning in 202 3 and continuing into coming quarters.
EVGO · Q2 2022 → YESThe question is about whether management explains why the business is about to be meaningfully larger based on already-taken actions of external parties, with at least two separate such parties, and t...YES The transcript shows management framing the company's growth as driven by external parties' already-completed actions: the GM-Pilot partnership (signed and announced, with EVgo to procure/construct/operate/maintain up to 2,000 stalls and 500 locations, delivering near-term revenue and contracted cash flows), the 2023 Cadillac LYRIQ charging offer (commercial agreement signed), the Philadelphia municipal fleet partnership (announced and operational), the GSA BPA award (five-year blanket purchase agreement now in place for federal agencies), and the California Energy Commission grant (selected for $3.6 million to build fast charging).
PRIM · Q2 2018 → YESThe question is about whether management explains why the business is about to be meaningfully larger based on already-taken actions of at least two separate external parties, and the reported results...YES The transcript shows management framing the business as about to become meaningfully larger primarily through external parties' already-completed actions: (1) the Willbros acquisition closed June 1, 2018, with Willbros now contributing $61 million revenue and $6.8 million gross profit in June alone (one month 2018 results), and (2) three separate major customers—previously hesitant due to Willbros' prior financial concerns—have now awarded work to the newly acquired T&D Group, with the largest MSA award announced and two additional awards leaking out, all within the first two months post-acquisition.